Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced Inflammation on Both Sides...
Faex Health Announces Investigational AI Screening Capabilities for Ebola and H. pylori, Expanding Gut Health Platform to 18 Conditions